期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
低氧诱导型VEGF真核表达载体的构建及其体外递送的应用与功能鉴定 被引量:2
1
作者 林彦霞 白睿 +4 位作者 刘志强 杨锡琴 金至赓 田鹏 刘惠亮 《解放军医学杂志》 CAS CSCD 北大核心 2019年第2期98-106,共9页
目的构建低氧诱导型的血管内皮生长因子(VEGF)真核表达载体,建立体外递送方法并对其效能进行鉴定。方法应用基因重组技术,在真核表达载体pGL4.73[hRluc/SV40](pSV)启动子上游插入促红细胞生成素(EPO)增强子,构建低氧诱导型表达载体(pEPO... 目的构建低氧诱导型的血管内皮生长因子(VEGF)真核表达载体,建立体外递送方法并对其效能进行鉴定。方法应用基因重组技术,在真核表达载体pGL4.73[hRluc/SV40](pSV)启动子上游插入促红细胞生成素(EPO)增强子,构建低氧诱导型表达载体(pEPO-SV),以海肾荧光素酶(Rluc)为下游报告基因;随后以VEGF165基因取代Rluc插入到pEPO-SV质粒,同时将其插入到pSV质粒作为对照,分别获得pEPO-SV-VEGF和pSV-VEGF表达载体;在体外分别将表达Rluc或VEGF165的质粒转染人胚肾293T细胞,在正常和低氧条件下处理24h和48h后,通过Rluc或VEGF165的表达对所构建载体的低氧诱导功能进行鉴定;然后基于聚乳酸-羟基乙酸共聚物(PLGA)纳米颗粒建立质粒的细胞内递送方法,并在体外细胞缺氧模型中对上述低氧诱导型真核表达质粒的效能进行鉴定。结果在质粒构建中,分别通过酶切、PCR扩增和DNA测序证实了EPO增强子和VEGF165基因的成功插入与正确性。表达Rluc或VEGF165的质粒分别转染293T细胞后,正常培养条件下报告基因Rluc(其一质粒pSV和pEPO-SV荧光表达值分别为2448.24±158.51和3173.97±379.92,其二质粒pSV和pEPO-SV荧光表达值分别为55 500.00±3237.05和51 193.18±866.32)及目的基因VEGF165表达差异无统计学意义(P>0.05),而在低氧情况下Rluc(氯化钴低氧下,质粒pSV和pEPO-SV荧光表达值分别为4857.70±1223.28和16 432.64±1618.73;低氧培养箱中,质粒pSV和pEPO-SV荧光表达值分别为2504.45±213.20和17 274.35±685.60)及VEGF165表达明显高于对照组,差异有统计学意义(P<0.01),表明所构建的pEPO-SV和pEPO-SVVEGF质粒具有典型的低氧诱导表达活性。利用PLGA纳米颗粒在体外293T细胞中进行pEPO-SV与pSV递送后,在正常培养条件下与低氧条件下报告基因Rluc的表达变化与上述一致,即正常培养条件下,处理24h与48h后pSV、pEPO-SV质粒的荧光表达值分别为149.44±4.01、127.09±15.05与1074.91±114.78、1064.56±137.48;低氧条件下,处理24h和48h后pSV、pEPO-SV质粒的荧光表达值分别为3265.34±440.00、8828.87±637.03与3202.06±33.43、9114.75±292.06。结论成功建立了典型的低氧诱导型VEGF真核表达系统,并建立了有效的体外递送方法;这一低氧诱导型表达载体及递送方法在缺血、缺氧等组织损伤疾病中可能具有重要的应用前景。 展开更多
关键词 VEGF165基因 真核表达 DNA重组技术 PLGA纳米粒
下载PDF
Randomized study on the safety and efficacy of dual-axis rotational versus standard coronary angiography in the Chinese population 被引量:3
2
作者 LIU Hui-liang jin zhi-geng +4 位作者 YANG Sheng-li LUO Jian-ping MA Dong-xing LIU Ying HAN Wei 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第6期1016-1022,共7页
Background Dual-axis rotational coronary angiography (DARCA) was developed as an innovative adaptation of rotational angiography (RA), but it requires a longer coronary injection compared to standard coronary angi... Background Dual-axis rotational coronary angiography (DARCA) was developed as an innovative adaptation of rotational angiography (RA), but it requires a longer coronary injection compared to standard coronary angiography (SA). As the body of the average Chinese patient is smaller than that of most western patients, with the same contrast injection time, the risk of complications from the contrast agent is increased in this population. The purpose of this study was to assess the clinical safety and efficacy of DARCA in the diagnosis of coronary artery disease (CAD) in the Chinese population by directly comparing it to SA. Methods Two hundred Chinese patients were randomized to either the SA group (n=100) or DARCA group (n=100). Contrast utilization, radiation exposure and procedure time were recorded for each modalities. Blood pressure (BP), heart rate (HR) pre and post injection symptoms and any arrhythmias were recorded. Results Compared to the SA group, there was a 42% reduction in contrast utilization, 55% reduction in radiation exposure and a 31% shorter procedure time in the DARCA group. In both groups, there were slight declines in the systolic BP values in the left coronary artery (LCA) post injection (P 〈0.01). Moreover, post injection HRs for the LCA were also reduced in the DARCA group (P 〈0.01). But all of these changes were small, transient and without clinical importance. Only one patient (1%) in the DARCA group had an attack of ventricular tachycardia immediately post injection and it resolved by itself during LCA angiography. No arrhythmias occurred in the SA group. Conclusion DARCA is a safe, efficient, and clinically comparable alternative to SA in the diagnosis of coronary artery disease in the Chinese population with less contrast utilized, which is less radiation exposure and a shorter procedure 展开更多
关键词 coronary artery angiography rotational coronary angiography dual-axis angiography contrast media radiation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部